Roche Holding AG (ROG)’s top-selling drug Rituxan effectively cured most cases of a rare and deadly skin disease in a patient study that suggests the medicine may replace steroids as the standard treatment. In a trial among 22 people with…
- Inicio
- Sobre nosotros
- Viviendo con P/P
- Investigación
- Involucrarse
- Noticias & Info
- Discussion Forums
